EcoDrugPlus

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSMPUG00000006126
Gene Symbol: PSMA3
2 Cross references
235 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSMPUG00000010971
Gene Symbol: PSMA4
2 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSMPUG00000003189
Gene Symbol: PSMA5
2 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSMPUG00000016288
Gene Symbol: PSMA6
2 Cross references
272 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSMPUG00000007664
Gene Symbol: PSMA7
2 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSMPUG00000006359
Gene Symbol: PSMA8
2 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSMPUG00000007150
Gene Symbol: PSMB1
2 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSMPUG00000006787
Gene Symbol: PSMB10
2 Cross references
171 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSMPUG00000014891
Gene Symbol: PSMB2
2 Cross references
220 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSMPUG00000003725
Gene Symbol: PSMB4
2 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSMPUG00000007019
Gene Symbol: PSMB5
2 Cross references
218 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSMPUG00000010838
Gene Symbol: PSMB6
2 Cross references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).